Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Getting to Know the Molecular Landscape of R/R Chronic Myeloid Leukemia: NGS-Based Profiling of Myeloid Mutations Beyond BCR/ABL

Roberto Ovilla-Martínez, Pamela E Baez Islas, Carmen Alaez-Verson, Nishalle E Ramirez Muniz, Fernando Perez-Jacobo, Gabriel Barragan-Ibañez, Mercedes González, Jesus Manuel L Lopez Valles, Laura I Banda-García, Eduardo E. Reynoso, Gregorio Campos Cabrera, Uendy Perez-Lozano, Samanta Tingen Velarde, Yolanda Lugo-García, Ana Carolina Reynoso, Jose L. Alvarez, Hiram U Severino-Lugo, Gilberto Israel Barranco Lampón

Blood (2023) 142 (Supplement 1): 6361.

https://doi.org/10.1182/blood-2023-181162

Published: 2023

Journal Articles

Regulation of Oxidative Energy Metabolism By G0S2 in FLT3 + AML

Mayra A. Gonzalez, Jose L. Lopez, Vanessa V. Velazquez, Mariah Perkins, Idaly M. Olivas, Alfonso E. Bencomo, Andres J. Rubio, Jehu N. Apaflo, Sudip Bajpeyi, Anna M. Eiring

Blood (2022) 140 (Supplement 1): 2984–2985.

https://doi.org/10.1182/blood-2022-155560

Published: 2022

Journal Articles

19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)

Joshua J. Lara, Alfonso E. Bencomo, Mayra A. Gonzalez, Idaly M. Olivas, Jose L. Lopez, James E. Young, Vanessa V. Velazquez, Steven Glovier, Andres J. Rubio, Sara K. Dang, Jonathan Solecki, Jesse Allen, Desiree N. Tapia, Boranai Tychhon, Gonzalo E. Astudillo, Darshan S. Chandrashekar, Anna M. Eiring

Blood (2022) 140 (Supplement 1): 3381–3382.

https://doi.org/10.1182/blood-2022-162818

Published: 2022

Journal Articles

A Role for Lipid Metabolism in Tyrosine Kinase Inhibitor (TKI) Resistance of Chronic Myeloid Leukemia (CML)

Mayra A. Gonzalez, Jose L. Lopez, Katherine Schenkel, Kelaiah Reffell, Christopher A. Eide, Sudip Bajpeyi, Anna M. Eiring

Blood (2021) 138 (Supplement 1): 2542.

https://doi.org/10.1182/blood-2021-148507

Published: 2021

Journal Articles

The Use of Busulphan As Compared to Melphalan in Combination with Fludarabine in the Reduced Intensity Conditioning Improves Overall Survival in Patients with Lymphoma

Natasha Kekre, MD FRCPC, Francisco J Marquez-Malaver, RN, Dolores Caballero, MD, Jl Piñana, MD, Albert Esquirol, MD, Robert J. Soiffer, MD, Monica Cabrero, MD, MJ Terol, Rodrigo Martino, MD PhD, Joseph H. Antin, MD, L Lopez Corral, Carlos Solano, Philippe Armand, MD PhD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 2007.

https://doi.org/10.1182/blood.V126.23.2007.2007

Published: 2015

Journal Articles

Nilotinib Shows Safety and Efficacy in Older Patients (≥ 65 years) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Comparable with That in Younger Patients with Chronic Myeloid Leukemia in Chronic Phase: Results From ENESTnd,

Richard A. Larson, MD, Udomsak Bunworasate, MD, Anna G. Turkina, MD, PhD, Stuart L. Goldberg, MD, Pedro Dorlhiac-Llacer, MD, Jose L. Lopez, MD, Hagop M. Kantarjian, Giuseppe Saglio, MD, Andreas Hochhaus, MD, Albert Hoenekopp, MD, Rick E. Blakesley, PhD, Richard Yu, Neil J. Gallagher, MD, PhD, Richard E. Clark, MD, Timothy P. Hughes, MD, MBBS

Blood (2011) 118 (21): 3768.

https://doi.org/10.1182/blood.V118.21.3768.3768

Published: 2011

Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Blood (2011) 118 (21): 1701.

https://doi.org/10.1182/blood.V118.21.1701.1701

Published: 2011

Journal Articles

Cardiac Safety Profile of Imatinib and Nilotinib In Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Results From ENESTnd

Richard A. Larson, MD, Andreas Hochhaus, MD, Giuseppe Saglio, MD, PhD, Gianantonio Rosti, MD, Jose L. Lopez, MD, Leif Stenke, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Stuart L. Goldberg, M.D., Ming-Chung Wang, MD, Neil J. Gallagher, MD, PhD, Albert Hoenekopp, MD, Christine-Elke Ortmann, Timothy P. Hughes, MD, MBBS, Hagop M. Kantarjian, MD

Blood (2010) 116 (21): 2291.

https://doi.org/10.1182/blood.V116.21.2291.2291

Published: 2010

Journal Articles

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

Blood (2010) 116 (8): e12–e17.

https://doi.org/10.1182/blood-2010-02-270009

Published: 2010

Journal Articles

Frequency of BCR/ABL Breakpoints in CML Venezuelan Patients : Contribution to a Possible Worldwide Distribution of BCR/ABL Transcripts Associated to Ethnicity

Fanny J. Carreño, Ph.D., Jose L Lopez, MD, Estluz K Mata, LIC, Leonor Cardenas, MD, Osiris Da Costa, MD, Carlos Mendez, LIC., Rene Utrera, Ph.D.

Blood (2008) 112 (11): 4280.

https://doi.org/10.1182/blood.V112.11.4280.4280

Published: 2008

Journal Articles

Conservative Whole Blood Extended Differential Method.

Ronald Paul, PhD, Lidice L. Lopez, BS, Diana B. Careaga, MT, Oilda Rubio, Ravindra Mylvaganam, PhD

Blood (2007) 110 (11): 3846.

https://doi.org/10.1182/blood.V110.11.3846.3846

Published: 2007

Journal Articles

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Brady Beltran-Garate, MD, Henry Gomez, MD, Jose L. Lopez, MD, Mildred Borrego, MD, Mercedes Prieto, MD, Antonio A. Carrasco-Yalan, MD, Julia Huamani, PharmD, Jorge Castillo, MD, Osiris da Costa, MD

Blood (2007) 110 (11): 3425.

https://doi.org/10.1182/blood.V110.11.3425.3425

Published: 2007

Journal Articles

Arginase Activity Is a Determinant of Nitric Oxide Levels in Adult Vasoocclusive Sickle Cell Crisis.

Bernard L. Lopez, MD, MS, Dana Telem, Pamela Flenders, MSN, Xin L. Ma, MD, PhD, Samir K. Ballas, MD

Blood (2004) 104 (11): 1670.

https://doi.org/10.1182/blood.V104.11.1670.1670

Published: 2004

Journal Articles

Survival of recombinant erythropoietin in the circulation: the role of carbohydrates

MN Fukuda, H Sasaki, L Lopez, M Fukuda

Blood (1989) 73 (1): 84–89.

https://doi.org/10.1182/blood.V73.1.84.84

Published: 1989

NARROW

Getting to Know the Molecular Landscape of R/R Chronic Myeloid Leukemia: NGS-Based Profiling of Myeloid Mutations Beyond BCR/ABL

Regulation of Oxidative Energy Metabolism By G0S2 in FLT3 + AML

19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)

A Role for Lipid Metabolism in Tyrosine Kinase Inhibitor (TKI) Resistance of Chronic Myeloid Leukemia (CML)

The Use of Busulphan As Compared to Melphalan in Combination with Fludarabine in the Reduced Intensity Conditioning Improves Overall Survival in Patients with Lymphoma

Nilotinib Shows Safety and Efficacy in Older Patients (≥ 65 years) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Comparable with That in Younger Patients with Chronic Myeloid Leukemia in Chronic Phase: Results From ENESTnd,

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Cardiac Safety Profile of Imatinib and Nilotinib In Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Results From ENESTnd

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

Frequency of BCR/ABL Breakpoints in CML Venezuelan Patients : Contribution to a Possible Worldwide Distribution of BCR/ABL Transcripts Associated to Ethnicity

Conservative Whole Blood Extended Differential Method.

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Arginase Activity Is a Determinant of Nitric Oxide Levels in Adult Vasoocclusive Sickle Cell Crisis.

Survival of recombinant erythropoietin in the circulation: the role of carbohydrates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only